Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE: PFE) has announced a public webcast featuring a discussion with Albert Bourla, Chairman and CEO, at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025, at 9:45 a.m. PST.
The webcast will be accessible through www.pfizer.com/investors, with registration details available immediately. A transcript and replay will be posted within 24 hours and remain accessible for at least 90 days.
Pfizer, with a 175-year legacy, focuses on developing breakthrough therapies and vaccines that improve lives globally. The company emphasizes quality, safety, and value in healthcare product development, working across developed and emerging markets to advance wellness and treatments for major diseases. They collaborate with healthcare providers, governments, and communities to expand access to affordable healthcare worldwide.
Pfizer Inc. (NYSE: PFE) ha annunciato un webcast pubblico che prevede una discussione con Albert Bourla, Presidente e CEO, durante il 43° Annuale J.P. Morgan Healthcare Conference il 13 gennaio 2025, alle 9:45 PST.
Il webcast sarà accessibile su www.pfizer.com/investors, con i dettagli per la registrazione disponibili immediatamente. Un transcript e la registrazione saranno pubblicati entro 24 ore e resteranno accessibili per almeno 90 giorni.
Pfizer, con una storia di 175 anni, si concentra sullo sviluppo di terapie e vaccini innovativi che migliorano la vita a livello globale. L'azienda pone l'accento sulla qualità, sicurezza e valore nello sviluppo di prodotti sanitari, operando in mercati sviluppati ed emergenti per promuovere il benessere e i trattamenti per le principali malattie. Collabora con fornitori di assistenza sanitaria, governi e comunità per ampliare l'accesso a cure sanitarie accessibili in tutto il mondo.
Pfizer Inc. (NYSE: PFE) ha anunciado un webcast público que contará con una discusión con Albert Bourla, Presidente y CEO, en la 43ª Conferencia Anual de J.P. Morgan sobre Salud el 13 de enero de 2025, a las 9:45 a.m. PST.
El webcast estará disponible en www.pfizer.com/investors, con detalles de registro disponibles de inmediato. Una transcripción y repetición se publicarán dentro de las 24 horas y permanecerán accesibles durante al menos 90 días.
Pfizer, con una herencia de 175 años, se centra en desarrollar terapias y vacunas innovadoras que mejoran vidas a nivel global. La compañía enfatiza la calidad, seguridad y valor en el desarrollo de productos de salud, trabajando en mercados desarrollados y emergentes para avanzar en el bienestar y tratamientos para enfermedades importantes. Colaboran con proveedores de atención médica, gobiernos y comunidades para expandir el acceso a atención médica asequible en todo el mundo.
화이자 주식회사 (NYSE: PFE)는 알버트 불라 회장 겸 CEO와의 대화를 주제로 다룬 공개 웹캐스트를 제43회 JP모건 헬스케어 컨퍼런스에서 2025년 1월 13일 오전 9시 45분 PST에 발표한다고 발표했습니다.
웹캐스트는 www.pfizer.com/investors에서 접속할 수 있으며, 등록 세부정보는 즉시 제공됩니다. 전사본 및 재방송은 24시간 이내에 게시되며 최소 90일 동안 이용 가능합니다.
175년의 역사를 가진 화이자는 전 세계적으로 삶을 개선하는 혁신적인 치료제 및 백신 개발에 집중하고 있습니다. 이 회사는 품질, 안전성 및 가치를 헬스케어 제품 개발의 핵심으로 삼고, 선진 시장과 신흥 시장에서 주요 질병에 대한 웰빙과 치료를 증진하기 위해 노력하고 있습니다. 이들은 의료 제공자, 정부 및 지역 사회와 협력하여 전 세계적으로 저렴한 건강 관리 접근성을 확대합니다.
Pfizer Inc. (NYSE: PFE) a annoncé un webinaire public avec une discussion dirigée par Albert Bourla, Président et PDG, lors de la 43e Conférence Annuelle J.P. Morgan sur les Soins de Santé le 13 janvier 2025 à 9h45 PST.
Le webinaire sera accessible via www.pfizer.com/investors, avec les détails d'inscription disponibles immédiatement. Un procès-verbal et un replay seront mis en ligne dans les 24 heures et resteront accessibles pendant au moins 90 jours.
Fort de 175 ans d'histoire, Pfizer se concentre sur le développement de thérapies et de vaccins innovants qui améliorent la vie dans le monde entier. L'entreprise met l'accent sur la qualité, la sécurité et la valeur dans le développement de produits de santé, et travaille sur des marchés développés et émergents pour faire progresser le bien-être et les traitements pour les maladies majeures. Ils collaborent avec des prestataires de soins de santé, des gouvernements et des communautés pour élargir l'accès à des soins de santé abordables dans le monde entier.
Pfizer Inc. (NYSE: PFE) hat ein öffentliches Webcast angekündigt, das eine Diskussion mit Albert Bourla, Vorsitzender und CEO, während der 43. J.P. Morgan Healthcare Conference am 13. Januar 2025 um 9:45 Uhr PST beinhaltet.
Das Webcast wird über www.pfizer.com/investors zugänglich sein, wobei die Registrierungsdetails sofort verfügbar sind. Ein Transkript und eine Aufzeichnung werden innerhalb von 24 Stunden veröffentlicht und mindestens 90 Tage lang zugänglich bleiben.
Pfizer mit einer 175-jährigen Geschichte konzentriert sich auf die Entwicklung bahnbrechender Therapien und Impfstoffe, die das Leben weltweit verbessern. Das Unternehmen legt Wert auf Qualität, Sicherheit und Wert bei der Entwicklung von Gesundheitsprodukten und arbeitet in entwickelten sowie aufstrebenden Märkten, um das Wohlbefinden und die Behandlung schwerer Krankheiten zu fördern. Sie arbeiten mit Gesundheitsdienstleistern, Regierungen und Gemeinschaften zusammen, um den Zugang zu erschwinglicher Gesundheitsversorgung weltweit zu erweitern.
- None.
- None.
To view and listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today.
The transcript and webcast replay of the discussion will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live discussion and will be accessible for at least 90 days.
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on X at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
Disclosure Notice: The webcast may include forward-looking statements about, among other things, expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other developing data, revenue contribution and projections, potential pricing and reimbursement, potential market dynamics, size and utilization rates, growth, performance, timing of exclusivity and potential benefits; our anticipated operating and financial performance, including financial guidance and projections; reorganizations, business plans, strategy and prospects; strategic reviews; capital allocation objectives; plans for and prospects of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on growth opportunities; manufacturing and product supply; our ongoing efforts to respond to COVID-19, including our COVID-19 products our expectations regarding the impact of COVID-19 on our business, operations and financial results; and other statements about our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the
The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.
Category: Finance
View source version on businesswire.com: https://www.businesswire.com/news/home/20250106723835/en/
Media Contact:
PfizerMediaRelations@Pfizer.com
+1 (212) 733-1226
Investor Contact:
IR@Pfizer.com
+1 (212) 733-4848
Source: Pfizer Inc.
FAQ
When is Pfizer (PFE) presenting at the 2025 J.P. Morgan Healthcare Conference?
How long will Pfizer's (PFE) 2025 J.P. Morgan Conference webcast be available for replay?
Where can investors access Pfizer's (PFE) J.P. Morgan Healthcare Conference presentation?
Who will represent Pfizer (PFE) at the 2025 J.P. Morgan Healthcare Conference?
How quickly will Pfizer (PFE) make the conference transcript available?
